Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High thrombus platelet content is associated with a lower rate of first pass effect in stroke treated by endovascular therapy.
Delvoye F, Di Meglio L, Consoli A, Nomenjanahary MS, Dupont S, Labreuche J, Maier B, Piotin M, Blanc R, Escalard S, Boursin P, Hamdani M, Redjem H, Smajda S, Hébert S, Sabben C, de Noordhout AM, Jandrot-Perrus M, Lapergue B, Mazighi M, Ho-Tin-Noé B, Desilles JP. Delvoye F, et al. Among authors: boursin p. Eur Stroke J. 2022 Dec;7(4):376-383. doi: 10.1177/23969873221108740. Epub 2022 Jul 27. Eur Stroke J. 2022. PMID: 36478752 Free PMC article.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Une course contre la montre.
Boursin P, Debout C. Boursin P, et al. Soins. 2018 Sep;63(828):23-54. doi: 10.1016/j.soin.2018.06.007. Soins. 2018. PMID: 30213309 Free article. French. No abstract available.
[Semantics, epidemiology and semiology of stroke].
Boursin P, Paternotte S, Dercy B, Sabben C, Maïer B. Boursin P, et al. Soins. 2018 Sep;63(828):24-27. doi: 10.1016/j.soin.2018.06.008. Soins. 2018. PMID: 30213310 Free article. French.
[Acute phase of stroke: every minute counts].
Maïer B, Boursin P, Mazighi M. Maïer B, et al. Among authors: boursin p. Soins. 2018 Sep;63(828):28-31. doi: 10.1016/j.soin.2018.06.009. Soins. 2018. PMID: 30213311 Free article. French.
[Nursing support during thrombolysis in the neurovascular ICU].
Paternotte S, Dercy B, Désilles JP, Sabben C, Boursin P. Paternotte S, et al. Among authors: boursin p. Soins. 2018 Sep;63(828):36-40. doi: 10.1016/j.soin.2018.06.014. Soins. 2018. PMID: 30213314 Free article. French.
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Mazighi M, Richard S, Lapergue B, Sibon I, Gory B, Berge J, Consoli A, Labreuche J, Olivot JM, Broderick J, Duhamel A, Touze E, Qureshi AI, Yavchitz A, Escalard S, Desilles JP, Redjem H, Smajda S, Fahed R, Hébert S, Maïer B, Delvoye F, Boursin P, Maacha MB, Obadia M, Sabben C, Blanc R, Savatovsky J, Piotin M; BP-TARGET investigators. Mazighi M, et al. Among authors: boursin p. Lancet Neurol. 2021 Apr;20(4):265-274. doi: 10.1016/S1474-4422(20)30483-X. Epub 2021 Feb 26. Lancet Neurol. 2021. PMID: 33647246 Clinical Trial.
Effect of blood pressure variability in the randomized controlled BP TARGET trial.
Maïer B, Gory B, Lapergue B, Sibon I, Escalard S, Kyheng M, Labreuche J, de Havenon A, Petersen N, Anadani M, Gayat E, Boursin P, Ben Maacha M, Desilles JP, Blanc R, Piotin M, Halimi JM, Mazighi M; BP TARGET Investigators. Maïer B, et al. Among authors: boursin p. Eur J Neurol. 2022 Mar;29(3):771-781. doi: 10.1111/ene.15194. Epub 2021 Dec 17. Eur J Neurol. 2022. PMID: 34821437 Clinical Trial.
Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
Anadani M, Maïer B, Escalard S, Labreuche J, de Havenon A, Sabben C, Lapergue B, Gory B, Richard S, Sibon I, Desilles JP, Blanc R, Piotin M, Mazighi M; of behalf the BP-TARGET Study Group*. Anadani M, et al. Stroke. 2022 Mar;53(3):719-727. doi: 10.1161/STROKEAHA.121.036701. Epub 2022 Feb 3. Stroke. 2022. PMID: 35109685 Free article. Clinical Trial.
21 results